Skip to main content

Table 3 Demographic characteristics

From: Efficacy of premedication with intranasal dexmedetomidine for removal of inhaled foreign bodies in children by flexible fiberoptic bronchoscopy: a randomized, double-blind, placebo-controlled clinical trial

Variables

DEX Group

Control Group

P value

Age (months)

17.2 ± 6.3

18.0 ± 6.6

0.737

Sex (male/female)

15/5

14/6

0.723

Weight (Kg)

10.9 ± 2.2

10.8 ± 1.2

0.965

Site of foreign body (T/RB/LB/BB)

1/11/6/2

0/10/9/1

0.576

Duration of foreign body aspiration (days)

5.5(2.3–10.0)

6.0(3.3–10.8)

0.583

Time-lag between diagnosis and retrieval of foreign body (days)

2(1–3)

2(1–3)

0.904

Complications

 Obstructive emphysema

11 (55)

16(80)

0.091

 Pneumonia

18 (90)

20 (100)

0.147

 Atelectasis

4 (20)

1 (5)

0.151

Baseline value

 Heart rate (beats per minute)

136 ± 21

151 ± 14

0.015

 Respiratory rate (beats per minute)

37 ± 9

37 ± 5

0.911

 Oxygen saturation (%)

100(100–100)

100(100–100)

0.583

  1. Date are expressed as mean ± standard deviation, median (interquartile range) number of patients (percentage). T, tracheal; RB, right bronchus; LB, left bronchus; BB, both right and left bronchus. Duration of foreign body aspiration: time from foreign body aspiration to its removal